Asth Mxl Tablets contain Montelukast 10 mg and Levocetirizine dihydrochloride 5 mg. Montelukast is a leukotriene receptor antagonist that blocks cysteinyl leukotriene activity, which is involved in airway inflammation and bronchoconstriction. Levocetirizine is a second-generation H1-antihistamine that helps counter histamine-mediated allergic symptoms. Together, these ingredients provide complementary pharmacological actions relevant to allergic conditions. The product is presented as tablets in a 10 × 10 Alu-Alu pack. Use should follow clinical assessment and the approved product label; prescribing decisions should consider the patient’s condition and applicable clinical guidance.
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about Asth Mxl Tablets for professional use.